(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 16.78% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 9.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.69%.
Genedx Holdings's revenue in 2025 is $402,190,000.On average, 10 Wall Street analysts forecast WGS's revenue for 2025 to be $12,463,659,208, with the lowest WGS revenue forecast at $12,058,705,902, and the highest WGS revenue forecast at $13,011,112,143. On average, 10 Wall Street analysts forecast WGS's revenue for 2026 to be $15,396,029,864, with the lowest WGS revenue forecast at $14,350,261,797, and the highest WGS revenue forecast at $16,558,861,519.
In 2027, WGS is forecast to generate $18,550,098,724 in revenue, with the lowest revenue forecast at $16,571,001,447 and the highest revenue forecast at $20,174,536,682.